J Pharm Pharmacogn Res 2(Suppl. 1): S38, 2014
Special supplement with the abstract book of LATINFARMA 2013
CO 063: ALTERNATIVE METHODS AT THE END OF THE WORLD
Seeing at the new alternative methods technologies in the use of laboratory animals and with the wish of bring new contributions, we have launched a Regional Network with the aim to get integrated to the rest of the community.
From Aacytal (Argentina Association for Science and Technology Laboratory Animals), along Aucytal (Uruguayan Association of Animal Science and Technology Laboratory) and Asochical (Chilean Association for Laboratory Animal Science, we call to join us.
The reality show us that in our region there is little done so far in alternative technology, due to shortcomings in legislation and regulation on animal testing laboratory.
The lack of government financial investment in promoting this technology, preclude an important tool for achieving objectives.
Another weakness is the user ignorance to these new trends and the difficulty to leave traditional forms of their normal duties.
The irregularity in the legislation is a threat.
We believe to have sufficient strength to fulfill our mission and one of them is the support of the Association of Laboratory Animal Sciences in the region, which will facilitate the collection of information needed to build a network between areas of biomedical research, science education of life or biological product development, to generate a database.
How are we working?
We have opened an Internet portal that will propagate the message.
We are participating as speakers in events that help in spreading the theme, developing new alternative methods in ours institutions and using other strategies that have been developed previously and join our project.
Citation Format: Asprea M (2014) ALTERNATIVE METHODS AT THE END OF THE WORLD. [abstract]. In: Proceedings of the LATINFARMA 2013; 2013 October 21–25; La Habana, Cuba: SCF; J Pharm Pharmacogn Res 2(Suppl. 1): S38.
© 2014 Journal of Pharmacy & Pharmacognosy Research (JPPRes)